| scholarly article | Q13442814 |
| P356 | DOI | 10.1185/03007990802278453 |
| P698 | PubMed publication ID | 18601811 |
| P2093 | author name string | S Watanabe | |
| D Rosillon | |||
| A Stockis | |||
| B Astruc | |||
| M A Meeus | |||
| M M Troenaru | |||
| R Hulhoven | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2327-2337 | |
| P577 | publication date | 2008-07-03 | |
| P1433 | published in | Current Medical Research and Opinion | Q5195063 |
| P1476 | title | Effect of brivaracetam on cardiac repolarisation--a thorough QT study | |
| P478 | volume | 24 |
| Q28076065 | Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base |
| Q38694479 | Brivaracetam for the treatment of epilepsy |
| Q38195636 | Brivaracetam for the treatment of epilepsy in adults. |
| Q38739649 | Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus. |
| Q38922348 | Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy |
| Q38626838 | Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures |
| Q37388101 | Choice of an alternative lead for QT interval measurement in serial ECGs when Lead II is not suitable for analysis. |
| Q45364807 | Comparison of two methods of estimating reader variability in QT interval measurements in thorough QT/QTc studies. |
| Q36891212 | Emerging drugs for partial-onset epilepsy: a review of brivaracetam |
| Q38652806 | Evaluation of brivaracetam: a new drug to treat epilepsy |
| Q34788845 | Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines |
| Q47733662 | Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany. |
| Q26776317 | Profile of brivaracetam and its potential in the treatment of epilepsy |
| Q26825591 | Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI) |
| Q47853821 | Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy |
| Q92641106 | Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis |
| Q38614499 | The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy |
| Q33661017 | The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance |
| Q24646866 | Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development |
| Q30390285 | [Brivaracetam for add-on treatment in focal epilepsy]. |
Search more.